Forge Biologics

Forge Biologics is a gene therapy contract development and manufacturing organization (CDMO) based in Grove City, Ohio. Founded in 2020, the company is part of Ajinomoto Bio-Pharma Services and focuses on supporting gene therapy developers from early development through clinical trials and commercial production. The company specializes in scalable manufacturing services for gene therapies, particularly adeno-associated virus (AAV) vectors. Its 200,000 square foot facility features 20 custom-designed cGMP suites with a total bioreactor capacity of 20,000 liters. Forge Biologics offers a range of services, including research-grade manufacturing, process and analytical development, cGMP manufacturing, fill and finish operations, and integrated regulatory support. The company has developed proprietary technologies under its FUEL™ platform to enhance manufacturing efficiency and safety. Forge Biologics aims to enable access to life-changing gene therapies, partnering with biotech companies focused on regenerative medicine and genetic disease treatments. With a strong leadership team and significant funding, the company is positioned as a key player in the gene therapy manufacturing sector.